Boston Scientific is advancing...

Similar documents
Working at Boston Scientific. Ronan Emmett Human Resources

Vision. Mission. Hopelink s Values. Introduction. A community free of poverty

QiG INS Conference May 22, 2011

Championing patients every step of the way

a case to support THE HEART & VASCULAR CENTER

ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015

Position Profile Chief Executive Officer Feeding America San Diego San Diego, CA

JTI Switzerland. JTI Schweiz 3

Edwards Lifesciences. Patient-Focused Innovations for Structural Heart Disease and Critical Care Monitoring

ADM to Acquire Neovia and Probiotics International Limited. July 2, 2018

Adding Tomorrows. Corporate Engagement with the. KENNEDY, age 8

Purolite Life Sciences Brand Positioning Catalyst

January 30, 2018 Dow Wilson President and Chief Executive Officer

London Regional Cancer Program

Eli Lilly Canada. Providing Answers That Matter. CPM talks to Gaetano Crupi, President and General Manager, Eli Lilly Canada.

Boehringer Ingelheim Pharmaceuticals, Inc. & Univision. Making Diabetic Hispanics Healthier

Mr. Kevin Dwan. The Sabrina Foundation Center for Cardiovascular Health in Pregnancy

Environmental, Health and Safety

Executive Director Position Announcement August, 2018

DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM

Toward a healthier 2020

Strategic Plan

INDIANA UNIVERSITY SCHOOL OF PUBLIC HEALTH BLOOMINGTON

Dad needed to get off his blood thinner. His doctor told us about an alternative. It s called

A Blueprint for Breast Cancer Deadline 2020

DuPont Nutrition & Health Craig Binetti, President

2018 INFUSE CALL FOR INNOVATION

Wednesday 26 th November 2008 The ASX Company Announcements office: Chairman s AGM Address

Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC

Strategic Plan

Using the Mozambique National Quality Policy to Encourage Biomedical Research, Innovation, & Infrastructure Investment

Fast-Forwarding a Cure for Melanoma

Program Priorities 2018

Legendary. Performance. Excellence. A Family of Companies THE

UC San Diego HIV Institute Creating a Future Without HIV/AIDS

Summary of Research and Writing Activities In Cardiovascular Disease

1. The World Bank-GAVI Partnership and the Purpose of the Review

STRATEGIC PLAN

Corporate Multi-Site Teams Fundraising Tools

04 WE ARE DEVELOPING SAFER CHOICES 06 WE WORK AS PARTNERS 08

First and foremost we have the world s largest privately funded biomedical research group investing about $8 billion in 2008.

BALCHEM CORPORATION. Q Investor Relations Presentation

LEVINE CANCER INSTITUTE. Brand Articulation and Messaging Platform

CORPORATE RESPONSIBILITY

Supplemental Appendix

NWT SPCA. Advocates for Animals of the North. Strategic Plan Charitable Registration #BN RR0001

OPENING UP A NEW WORLD

A world leader in allergy immunotherapy

FY12 FY14 Strategic Plan

PROGRESS UPDATE. The Pan-Mass Challenge

Value creation through profitable growth Handelsbanken Nordic Large Cap Seminar, Stockholm 2016 Anders Lonning-Skovgaard, CFO

AutismTom Brundage. At Work. Employment Pathways 22 January Kristen Doran Senior Human Resources Business Partner Ireland

Fact Sheet. VitalStim Therapy

Chapter 1: The Optum Brand

MedSurg: Endoscopy Presentation for the Investment Community at DDW. Art Butcher Senior Vice President and President, Endoscopy

Food Specialties Patrick Niels President DSM Food Specialties ROYAL DSM HEALTH NUTRITION MATERIALS

Spiros Nomikos Chief Executive Officer Solvay Sodi Bulgaria

PARTNERS FOR A HUNGER-FREE OREGON STRATEGIC PLAN Learn. Connect. Advocate. Partners for a Hunger-Free Oregon. Ending hunger before it begins.

Use this pitch template if your hospital would like to promote a milestone implant number of the WATCHMAN device at your facility.

Innovator in Chelated Mineral Nutrition

ResMed Inc. 36 th Annual J.P. Morgan Healthcare Conference

Listen to Your Heart. What Everyone Needs To Know About Atrial Fibrillation & Stroke. The S-ICD System. The protection you need

ONLY AT NYSCF Stem Cells in the City Sponsorship Offering

Detroit Chapter. Corporate Participation Prospectus. Detroit Chapter. "Developing Leaders and Redefining Success"

Integrating Project Management Standards within Business Technology Management (BTM)

Investor Presentation. Q April 26, 2018

Fulfilling Our Promise

Community Leadership Council. October 9, 2018

Watchman. Left Atrial Appendage Closure Device. Uniquely engineered for the LAA 1-3 with proven safety and longterm efficacy. 4-8

Boehringer Ingelheim and investment in R&D. Volker Barkmann

Strategy at Work. MedStar Health. Engaging people, improving performance

United Way Suncoast Women United. March 19, 2018 LOCATION unitedwaysuncoast.org

STRATEGIC PLAN

YES. Your Guide to Getting WATCHMAN. Is a life without blood thinners possible?

LIFE MOVES US CORPORATE OVERVIEW

empower youth mentor

Health for Humanity 2020 Goals 2

Table of Contents. 1. About Solvay Solvay at a Glance Group Portfolio Transforming Solvay Solvay s Portfolio Upgrade 7

Bank of America Chicago Marathon Sunday, October 9, Corporate Sponsorship Opportunities

The MGH Journey. Shaping the Future of an Entire Region

- Plans Commercial Launch of three dosing options for Excellagen in pre-filled syringes

Annual Ideagen UN Empowering Women & Girls 2030 Summit

Itamar Medical. December Investors Presentation.

Here for You When You Need Us

Putting ALK on the right growth trajectory

Mount Prospect, Illinois

The summit and its purpose

Neurofibromatosis (NF) Center

Global Spine Market with Focus on Spinal Fusion: Industry Analysis & Outlook ( )

UNMC Nebraska Medicine Strategic Plan

SECTION 3: WHAT DOES DIABETES UK DO?

Delivering Results POSITIONED FOR GROWTH. Analyst & Investor Day October 14, 2015 Paul Guggenheim CEO, Patterson Dental

CREATING SHARED VALUE Nestlé and Nestlé Purina in the U.S.

Support Facilitator Partners in Recovery - Ashfield

Transcatheter Heart Valve Therapy

Heart & Vascular Institute Outcomes

Summary Transforming healthcare for women and newborns

The National Pancreas Foundation. Volunteering Policy & Engagement Procedure

We are a network of successful REALTORS, advancing women as professionals and leaders in business, the industry and the communities we serve.

Transcription:

Boston Scientific is advancing...

Our mission Our values Boston Scientific is dedicated to transforming lives through innovative Caring Meaningful Innovation High Performance medical solutions that improve the health of patients around the world. We act with integrity and compassion to support patients, customers, our communities and each other. We advance science through medical technologies that decrease the physical and emotional impact on patients and reduce the cost of healthcare. We strive for high performance to benefit our patients, clinicians and shareholders. Global Collaboration Diversity Winning Spirit We work collaboratively to pursue global opportunities that extend the reach of our medical solutions. We embrace diversity and value the unique talents, ideas and experiences of our employees. We adapt to change and act with speed, agility and accountability to further improve patient care....science for life. 2 3

Our heritage Our core Boston Scientific was founded in 1979 with a clear purpose to benefit At Boston Scientific, we believe that only an innovation realized can improve public health by bringing more accessible, lower-cost, health, change an outlook or transform a life. That s why we re committed to and lower-trauma medical options to patients. For more pioneering, innovating and advancing science. Our heritage of discovery continues than three decades, Boston Scientific has fulfilled to drive our passion for meaningful innovations that help patients live healthier, that purpose by advancing medical science through longer lives. the development and commercialization of transformative medical technologies. Today, as a global market leader, Boston Scientific invests nearly $1 billion annually to innovate and bring to market medical devices and procedures that address unmet clinical needs and reduce the frequency of patient re-intervention. Our unwavering focus on quality and patient outcomes and our collaborative relationships with clinicians make us a provider of choice for Interventional Cardiology Neuromodulation Electrophysiology What began in the late 1960s as a family of steerable catheters that ushered in an era of less-invasive procedures has grown to one of the broadest and deepest portfolios of medical solutions in our industry. innovative products, technologies and services across a wide range of medical specialties. Cardiac Rhythm Management Endoscopy Urology and Women s Health Peripheral Interventions 4 5

Our advancements With the caring and winning spirit of our diverse workforce, we plan to maximize global opportunities and push the boundaries of today s medical solutions that lead to tomorrow s meaningful innovations. Today we are... Minimizing sudden cardiac death through implantable devices Offering less-invasive options in the fight against cardiovascular disease Relieving symptoms for those who suffer from chronic pain, and treating patients with Parkinson s disease 1 Treating pelvic floor disorders so women may improve their quality of life Diagnosing and treating heart rhythm disorders Treating patients with life-limiting vascular and venous diseases Treating a variety of digestive and pulmonary diseases Reducing urinary discomfort caused by kidney and bladder stones Tomorrow, we plan to... Offer more patients a way to protect their heart without touching it Bring innovative technologies to more markets for patients with atrial fibrillation Offer minimally invasive 4 treatments for valve disorders 2 Offer relief to patients with neurological movement disorders 3 Offer innovative solutions to treat a broader group of women Treat hypertension and cancer through catheterbased therapies 5 Improve lives for more asthma sufferers and extend treatment to emphysema sufferers Increase global patient access to urologic treatments through cost-effective technologies 1 Boston Scientific currently has approval for Parkinson s disease in the EU only. 6 2,3,4,5 Shown above is the Lotus Aortic Valve System (a transcatheter aortic valve replacement (TAVR) device)(2), an investigational device worldwide and not available for sale. Also shown above is the Guide DBS Programming System(3), the WATCHMAN Left Atrial Appendage (LAA) Closure Device(4), and the Vessix Renal Denervation System(5). In the U.S., these are investigational devices and not available for use or sale. Watch our corporate video to see how we are advancing science for life. 7

Our corporate citizenship At Boston Scientific, we are also committed to advancing opportunities that improve lives in the communities where we live and work. We bring this commitment to life through global, national and local health and education initiatives, improving patient advocacy and minimizing our impact on the environment. Patient Advocacy Close the Gap is Boston Scientific s health equity initiative. This program helps to ensure all patients have access to high quality cardiac care regardless of age, gender, race, ethnicity, or primary language. Close the Gap supports educational outreach programs in communities across the United States in partnership with health care providers, professional societies and patient advocacy groups. Health and Education The Boston Scientific Foundation is at work in clinics, schools and neighborhoods across the United States, helping to expand access to quality health care and educational opportunities for everyone. Since 2002, the Boston Scientific Foundation has donated more than $30 million to help charitable organizations. The Boston Scientific Foundation funds education programs dedicated to advancing the next generation of life science innovators by fostering an interest in math and science among children and pre-teens, and supporting budding high school-and college-aged scientists, engineers and clinicians. The Boston Scientific Foundation also supports disease prevention and awareness efforts to help people reduce their risk of chronic illness. Sustainability Environmental sustainability is an important consideration in our overall operations. By building infrastructure with environmental impact in mind, we are carefully using natural resources, minimizing recycling and reusing waste. With more than 70% of our major facilities already ISO14001- certified, we continue to reduce our carbon footprint and work toward our goal of 100% worldwide certification for design and implementation of effective environmental management systems. To learn more about our Corporate Citizenship Programs visit www.bostonscientific. com/citizenship. 8 9

Boston Scientific by the numbers 1 of the world s largest medical device companies 15,000+ patents issued; ~7,300 applications pending worldwide ~$886 million invested annually in R&D ~24,000 employees worldwide Market presence in nearly 100 countries worldwide $7.3 billion in annual sales $933 million adjusted net income* All numbers above as of December 31, 2012. *Adjusted net income excludes acquisition, litigation, divestiture, restructuring, and other charges. For reconciliations of our adjusted net income and other of our non- GAAP financial measures, please refer to the Investor Relations section of our website at www.bostonscientific.com To learn more about our history, leadership or businesses, please visit www.bostonscientific.com/us/about.html. Corporate Headquarters One Boston Scientific Place Natick, MA 01760-1537 United States 508-650-8000 www.bostonscientific.com CORP-133401-AB JULY2013